Alcohol abuse and alcoholism are responsible for a wide variety of medical problems. The pharmacotherapeutic aspect of alcoholism includes the use of drugs, with different actions and objectives. Among them, metadoxine seems to be of interest. Metadoxine is able to accelerate the elimination of alcohol from the blood and tissues, to help restore the functional structure of the liver and to relieve neuro-psychological disorders associated with alcohol intoxication. Metadoxine also seems to be safe; in more than 15 years of post-marketing surveillance only minor aspecific and reversible events were monitored in patients exposed to the treatment. In this review the preclinical and clinical results obtained using metadoxine in acute and chronic alcohol intoxication are reported.
SchuckitM.A.1986. Genetic and clinical implications of alcoholism and affective disorders. Am. J. Psychiatry143:140.
2.
SchukitM.A.GoldE.O., 1988. A simultaneous evaluation of multiple markers of ethanol/placebo challenges in sons of alcoholics and controls. Arch. Gen. Psychiatry45:211.
3.
LieberC.S.1995. Medical disorders of alcoholics. N. Engl. J. Med.333:1058.
4.
AdamsW.L.YuanZ.BarboriakJ.J.RimmA.A., 1993. Alcohol-related hospitalizations of elderly people. JAMA270:1222.
5.
LeevyC.M.1962. Fatty liver: A study of 270 patients with biopsy proven fatty liver and a review of literature. Medicine41:249.
6.
AddoloratoG.AnconaC.GasbarriniA., 2000. Role of alcohol abuse and hepatitis virus in liver cirrhosis: Hypothesis on action of ethanol as a cofactor. Alcohol Res. 5:237.
7.
SudzakP.D.PaulS.M.CrawleyJ.N., 1988. Effects of RO 15–4513 and other benzodiazepines receptor inverse agonists on alcohol induced intoxication in rat. J. Pharmacol. Exp. Ther.245:880.
8.
ImperatoA.Di ChiaraG., 1986. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exl. Ther.239:219.
9.
BrancheyL.BrancheyM.ZucherD.ShawS.LieberC.S., 1985. Association between low plasma tryptophan and blackouts in male alcoholic patients. Alcoholism9:393.
10.
WoodwardJ.J.GonzalesR.A., 1990. Ethanol inhibition of N-methyl-D-aspartate-stimulated endogenous dopamine release from rat striatal slices reverse by glucine. J. Neurochem.54:712.
11.
AndreassonS.AllebeckP.RomelsjicA., 1988. Alcohol and mortality among young men; longitudinal study of Swedish conscripts. Br. Med. J.296:1021.
12.
AddoloratoG.ArmuzziA.GasbarriniG., 2002. Pharmacological approaches to the management of alcohol addiction. Eur. Rev. Med. Pharmacol. Sci.6:89.
13.
WilkS.OrlowskiM., 1973. The occurrence of free L-pyrrolidone carboxylic in body fluids and tissues. Febs Lett. 12:157.
14.
AnnoniG.ContuL.TronciM.A., 1992. Pyridoxol 1, 2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCL4-treated rats. Pharmacol Res. 25:87.
15.
ShullK.H.KisilevskyR., 1971. Effects of L-2-Pyrrolidone-5-carboxylate on hepatic adenosine triphosphate levels in the ethionine treated rat. Biochem. Pharmacol.20:2781.
16.
LumenhsL.1978. The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal's-5-phosphale metabolism. J. Clin. Invest.62:286.
17.
FelicioliRSaracchiI.FlngielloA.M., 1980. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats. Int. J. Clin. Pharm. Ther. Toxicol.18:277.
18.
IzquierdoI.TonentJ., 1989. Bioequivalence study of two metadoxine formulations in healthy volunteers. Proc. Int. Congress. “Personality and psychopathology”, Pisa, p. 48.
19.
SegreG.1979. Kinetics of metadoxine in rat, dog and monkey after intravenous and oral administration. In: Report from the Institute of Pharmacology. University of Siena, Italy, p. 1.
20.
MateraM.ScapagniniU., 1981. Kinetics of absorption and distribution of metadoxine. In: Report from the Institute of Pharmacology. University of Catania, Italy, p. 1.
21.
RizzaV.ScapagniniU., 1981. Pharmacokinetics and bioavailability of metadoxine in rat animal model. In: Report from the Institute of Pharmacology. University of Catania, Italy, p. 1.
22.
CalabreseV.RagusaN.RizzaV., 1995. Effects of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during ethanol intake in rats. Int. J. Tiss. React.17:15.
23.
ParèX.MorenoA.PeralbaJ.M., 1991. Action of metadoxine on isolated human and rat alcohol and aldehyde dehydrogenases. Effect on enzymes in chronic ethanol fed rats. Met. Find. Exp. Clin. Pharm.13:37.
24.
CalabreseV.BombaciG.CalderoneA.RizzaV., 1993. Effects of metadoxine on cellular free fatty acid levels in ethanol treated rats. Int. J. Tiss. React.15:235.
25.
CalabreseV.CalderoneA.S.RagusaN.RizzaV., 1995. Effects of metadoxine on cellular formation of fatty acid ethyl esters in ethanol treated rats. Int. J. Tiss. React.17:101.
26.
CalabreseV.de BernardinisE.RizzaV., 1986. Ruolo della Metadoxina nel contrallo dello stress ossidativo da intossicazione etanolica acula e cronica. Boll. Soc. It. Biol. Sper.62:1357.
27.
CalabreseV.CalderoneA.RagusaN., 1996. Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats. Drugs Exp. Clin. Res.22:17.
28.
CalabreseV.RandazzoG.RagusaN.RizzaV., 1988. Long-term ethanol administration enhances age-dependent modulation of redox state in central and peripheral organs of rat: Protection by metadoxine. Drugs Exp. Clin. Res.24:85.
29.
Gutierrez-RuizM.C.BucioL.CorreaA., 2001. Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture. Pharmacol. Res.44:431.
30.
ArosioB.SantambrogioD.GaglianoN., 1993. Changes in expression of the albumin, fibronectin and type 1 procollagen genes in CCL4-induced liver fibrosis: Effect of pyridoxol L,2-pyrrolidon-5carboxylate. Pharmacol. Toxicol.73:301.
31.
AntonelliT.CarlaV.LambertiniL., 1984. Pyroglutamic acid administration modifies the electrocorticogram and increase of acetylcholine and GABA from the guinea-pig cerebral cortex. Pharmacol. Res. Commun.16:189.
32.
FornaiF.AlessandriM.G.BonuccelliU., 1993. Effect of Metadoxine on striatal dopamine levels in C57 black mice. J. Pharm. Pharmacol.45:476.
33.
BeniM.GimpietroD.E. PellegriniMoroniF., 1988. A new endogenous anxiolytic agent: L-pyroglutamic acid. Fundam. Clin. Pharmacol.2:77.
34.
GiampietroD.E. PellegriniMoroniF., 1989. Pyrrolidone carboxylic acid in acute and chronic alcoholism: Preclinical and clinical studies. Rec. Prog. Med.80:160.
35.
GarauB.FaddaF.MelisF., 1992. Metadoxine (pyrrolidone carboxylate of pyridoxine) antagonizes the locomotor-stimulatory effect of ethanol in mice. Alcohol. 27:501.
36.
Di IlioC.Del BoccioG.ArduiniA., 1982. Effetto della Metadoxina sull'alcolemia e sui livelli ematici di aleuni enzimi dopo ingestione di alcol. Ter. Essenz. Clin.12:803.
37.
Pellegrini-GiampietroD.E.MoroniF.PistelliA., 1989. Pyrrolidone Carboxylic acid in acute and chronic alcoholism. Preclinical and Clinical studies. Rec. Prog. Med.80:160.
38.
CalabreseV.CarlinoS.ChinniciV., 1986. La Metadoxina modula le cinetiche di ássorbimento, metabolismo ed eliminazione dell'etanolo. Alcologia5:44.
39.
BernikV.MaseiC.B.KatzP.D., 1982. Impiego della Metadoxina in casi di intossicazione alcoolica acuta. Rassegna Int. Clin. Ter.62:728.
40.
MoroniF.MasiniE.Pellegrini-GiampietroD.E., 1987. Preclinical pharmacology of pyrrolidone carboxylate of pyridoxine (metadoxine). In: Int. Symp. Neurotoxicology.Torino, p. 89.
41.
Laprevote-HeuillyM.C.LarcanA., 1981. Traitement par la Metadoxine des intoxications éthyliques aigües. Ann. Med. Nancy. Est.20:699.
42.
SantoniS.CorradiniP.ZocchiM., 1989. La Metadoxina nella patologia alcol-correlata. Clin. Ter.130:115.
43.
Diaz-MartinezM.C.Diaz-MartinezA.Villamil-SalcedoV.Cruz-FuentesC., 2002. Efficacy of metadoxine in the management of acute alcohol intoxication. J. Int. Med. Res.30:44.
44.
WeberF.R.Ibarrola-CallejaJ.L.Gonzales-JaregutM.M., 2003. Acute metadoxine treatment for acute alcohol intoxication in an Emergency Unit. In: Intensive Cure Medicine (in press).
45.
ShpilenyaL.S.MuzychenkoA.P.GasbarriniG.AddoloratoG., 2002. Metadoxine in acute alcohol intoxication: A double-blind, randomized, placebo-controlled study. Alcohol. Clin. Exp. Res.26:340.
46.
BonoG.SinforianiE.MerloP., 1991. Alcoholic abstinence syndrome: Short-term treatment with Metadoxine. Int. J. Clin. Pharm. Res.11:35.
47.
KochM.M.BazuroG.E.Del SetteF., 1989. L'approccio al paziente alcolista in un ambulatorio di gastroenterologia: Il possibile ruolo di un nuovo farmaco GABA agonista. Alcologia1:127.
48.
RizzoA.BredaA.MorettoM., 1993. Uso terapeutico della metadoxina nell'alcolismo cronico. Clin. Ther.142: 243.
49.
StefaniniG.F.AddoloratoG.CaputoF.GasbarriniG., 1999. Treatment of alcoholic fatty liver: Is the metabolic effect of metadoxine the only reason for improved liver function?J. Hepatol.30:739.
50.
FelicianiC.VerrottiA.CoscioneG.TotoP.MorelliF.Di BenedettoA.SalladiniC.ChiarelliF.TulliA., Skin reactions due to antiepileptic drugs: Several case-reports with long-term follow-up. Int. J. Immunopathol. Pharmacol.16:89.
51.
HuangS.H.GambiF.ContiF.CarratelliG.ContiC.M.V.MastromauroI.RiccioniG.GrilliA.BellatiU.DoyleR., Antiepileptic drugs lower contraceptive sex hormone and increase the risk of unplanned pregnancies in women with epilepsy: Revisited study. Int. J. Immunopathol. Pharmacol.16:181.
52.
CarboniM.A.CorsaR., 1987. Uso terapeutico della Metadoxina nei disturbi psichiei e comportamentali alcool-correlati. Clin. Ther.123:469.
53.
SinforianiE.MauriM.MerloP., 1990. Effects of Metadoxine on the early phase of cognitive recovery in abstinent alcoholics. Clin. Trials J. 27:103.
54.
CorsiniG.GelsoE.GiulianoG., 1992. Effetti della Metadoxina sulle principali alterazioni bio-umorali indotte dall'etilismo cronico. Clin. Ther.140:251.
55.
CaballeiraJ.ParesA.BruC., 1998. Metadoxine accelerates fatty liver recovery in alcoholic patients: Result of a randomized double-blind, placebo-control trial. J. Hepatol.28:54.
56.
AnnoniG.KhlatB.LamperticoP., 1988. Metadoxine (Metadoxil*) in alcoholic liver diseases. Clin. Trials J. 25:333.
57.
IntaschiG.LattanziL.LombardiG., 1989. Gli effetti della Metadoxina nella dipendenza da alcool: Implicazioni per lo studio dei rapporti tra alcolismo e depressione. In: Atti del XXXVII congresso della Soc. It. Psichiatria.Roma, p. 1.
58.
Sang-HoonP.Jong-EunY.Kwan-SooB., 1998. An efficacy evaluation of the oral Metadoxine administration in Korean alcoholic liver patients: A randomized, placebo-controlled trial. Kor. J. Clin. Pharmacol. Ther.6:134.
59.
SergiacomoL.CiancagliniR.OrlandoD., 1986. Trattamento dell'epatosteatosi alcolica con metadoxina. Risultati preliminari sulla valutazione dell'effetto del farmaco medianto studio ultrasonografico. Clin. Ther.119:133.
60.
CacciatoreL.LingettiM.TalaricoM.M.1986. Prime esperienze sull'efficacia della metadoxina nella steatosi epatica correlata all'abuso di alcol. Rif. Med.101:421.
